These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16321662)

  • 1. The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure.
    Chizzola PR; Gonçalves de Freitas HF; Marinho NV; Mansur JA; Meneghetti JC; Bocchi EA
    Int J Cardiol; 2006 Jan; 106(1):29-34. PubMed ID: 16321662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.
    Gerson MC; Craft LL; McGuire N; Suresh DP; Abraham WT; Wagoner LE
    J Nucl Cardiol; 2002; 9(6):608-15. PubMed ID: 12466785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.
    Toyama T; Hoshizaki H; Seki R; Isobe N; Adachi H; Naito S; Oshima S; Taniguchi K
    J Nucl Med; 2003 Oct; 44(10):1604-11. PubMed ID: 14530474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.
    Maunoury C; Acar P; Sidi D
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1651-6. PubMed ID: 14504829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure.
    Cohen-Solal A; Rouzet F; Berdeaux A; Le Guludec D; Abergel E; Syrota A; Merlet P
    J Nucl Med; 2005 Nov; 46(11):1796-803. PubMed ID: 16269592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
    Agostini D; Belin A; Amar MH; Darlas Y; Hamon M; Grollier G; Potier JC; Bouvard G
    J Nucl Med; 2000 May; 41(5):845-51. PubMed ID: 10809201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
    Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Eur Heart J; 2007 Apr; 28(8):989-95. PubMed ID: 17409109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2003 Jun; 44(6):884-90. PubMed ID: 12791814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of nonselective versus selective β-blockers on cardiac sympathetic activity and hemostasis in patients with heart failure.
    de Peuter OR; Verberne HJ; Kok WE; van den Bogaard B; Schaap MC; Nieuwland R; Meijers JC; Somsen GA; Bakx A; Kamphuisen PW
    J Nucl Med; 2013 Oct; 54(10):1733-9. PubMed ID: 23970363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short-term carvedilol on the cardiac sympathetic activity assessed by 123I-MIBG scintigraphy.
    Miranda SM; Mesquita ET; Dohmann HF; Azevedo JC; Barbirato GB; Freire Fde L; Ribeiro ML; Nóbrega AC; Coimbra A; Mesquita CT
    Arq Bras Cardiol; 2010 Mar; 94(3):308-12, 328-32. PubMed ID: 20730258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy.
    Fujimura M; Yasumura Y; Ishida Y; Nakatani S; Komamura K; Yamagishi M; Miyatake K
    J Card Fail; 2000 Mar; 6(1):3-10. PubMed ID: 10746813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ishikawa T; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Jul; 45(7):1108-13. PubMed ID: 15235055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
    Bergström A; Andersson B; Edner M; Nylander E; Persson H; Dahlström U
    Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of carvedilol on cardiac function and cardiac adrenergic neuronal damage in rats with dilated cardiomyopathy.
    Watanabe K; Takahashi T; Nakazawa M; Wahed MI; Fuse K; Tanabe N; Kodama M; Aizawa Y; Ashino H; Tazawa S
    J Nucl Med; 2002 Apr; 43(4):531-5. PubMed ID: 11937598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart.
    Merlet P; Pouillart F; Dubois-Randé JL; Delahaye N; Fumey R; Castaigne A; Syrota A
    J Nucl Med; 1999 Feb; 40(2):224-31. PubMed ID: 10025827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine-123 MIBG imaging before treatment of heart failure with carvedilol to predict improvement of left ventricular function and exercise capacity.
    Choi JY; Lee KH; Hong KP; Kim BT; Seo JD; Lee WR; Lee SH
    J Nucl Cardiol; 2001; 8(1):4-9. PubMed ID: 11182704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased myocardial beta-adrenergic receptor density in relation to increased sympathetic tone in patients with nonischemic cardiomyopathy.
    Tsukamoto T; Morita K; Naya M; Inubushi M; Katoh C; Nishijima K; Kuge Y; Okamoto H; Tsutsui H; Tamaki N
    J Nucl Med; 2007 Nov; 48(11):1777-82. PubMed ID: 17942801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure patients with B1-adrenoreceptor polymorphisms have augmented carvedilol response as detected by cardiac I123-MIBG scintigraphy.
    Miranda SM; Moscavitch SD; Pereira SB; de Azevedo JC; Messias LR; Rodrigues RC; Mesquita ET; Ribeiro GS; Mesquita CT
    Int J Cardiol; 2014 Nov; 177(1):111-3. PubMed ID: 25499350
    [No Abstract]   [Full Text] [Related]  

  • 19. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
    Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT
    J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.